Skip to main navigation

Contact Us

Search for:

About
Therapeutic Focus
- What is MASH?
Our Medicine
Careers & Culture
Investors & Media

Investors & Media
Back to Main Site

Press Releases
Events and Presentations
Financials and Filings
Stock Information
Corporate Governance
Investor FAQs
Email Alerts

Events and Presentations

Presentations

May 1, 2025

First-Quarter 2025 Financial Results Presentation

February 26, 2025

Fourth-Quarter 2024 Financial Results Presentation

October 30, 2024

Third-Quarter 2024 Financial Results Presentation

August 7, 2024

Second-Quarter 2024 Financial Results Presentation

March 14, 2024

Rezdiffra Approval Presentation

Upcoming Events

May 13, 2025 8:00 AM EDT

Rezdiffra 2-Year Compensated MASH Cirrhosis (F4c) Data at EASL 2025

Listen to webcast

Archived Events

May 1, 2025 8:00 AM EDT

Q1 2025 Earnings Call

Listen to webcast

First-Quarter 2025 Financial Results Presentation 886.8 KB

Press Release 315.5 KB

Mar 4, 2025 11:10 AM EST

TD Cowen 45th Annual Health Care Conference

Listen to Webcast

Feb 26, 2025 8:00 AM EST

Q4 2024 Earnings Call

Listen to Webcast

Fourth-Quarter 2024 Financial Results Presentation 940.7 KB

Press Release 376.3 KB

Jan 15, 2025 5:15 PM EST

43rd Annual J.P. Morgan Healthcare Conference

Listen to Webcast

Press Release 804.7 KB

43rd Annual J.P. Morgan Healthcare Presentation 1.3 MB

Dec 5, 2024 8:30 AM EST

Piper Sandler 36th Annual Healthcare Conference

Listen to Webcast

Dec 4, 2024 9:35 AM EST

7th Annual Evercore HealthCONx Conference

Listen to Webcast

About
Therapeutic Focus
Our Medicine
Careers & Culture
Investors & Media
Contact Us
Terms of Use
Privacy
Cookies
Transparency
CA Compliance

Twitter

© 2025 Madrigal Pharmaceuticals, Inc. All rights reserved.

The information on this website is intended
for residents of the United States only.
US-CORP-MDGL-00002